BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18615458)

  • 1. Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells.
    Moon JS; Lee MY; Park SW; Han WK; Hong SW; Ahn JH; Kim KS
    Prostate; 2008 Sep; 68(13):1450-60. PubMed ID: 18615458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
    Huang H; Zegarra-Moro OL; Benson D; Tindall DJ
    Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
    Gavrielides MV; Gonzalez-Guerrico AM; Riobo NA; Kazanietz MG
    Cancer Res; 2006 Dec; 66(24):11792-801. PubMed ID: 17178875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rap2 regulates androgen sensitivity in human prostate cancer cells.
    Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D
    Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.
    Kvissel AK; Ramberg H; Eide T; Svindland A; Skålhegg BS; Taskén KA
    Cell Signal; 2007 Feb; 19(2):401-9. PubMed ID: 16949795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
    Péant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM
    Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells.
    Wang G; Jones SJ; Marra MA; Sadar MD
    Oncogene; 2006 Nov; 25(55):7311-23. PubMed ID: 16751804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation.
    Prösch S; Wendt CE; Reinke P; Priemer C; Oppert M; Krüger DH; Volk HD; Döcke WD
    Virology; 2000 Jul; 272(2):357-65. PubMed ID: 10873779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
    Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.
    Mehraein-Ghomi F; Lee E; Church DR; Thompson TA; Basu HS; Wilding G
    Prostate; 2008 Jun; 68(9):924-34. PubMed ID: 18386285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
    Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
    Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
    Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
    Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.
    Butcher NJ; Tetlow NL; Cheung C; Broadhurst GM; Minchin RF
    Cancer Res; 2007 Jan; 67(1):85-92. PubMed ID: 17210686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.
    Moon JS; Jin WJ; Kwak JH; Kim HJ; Yun MJ; Kim JW; Park SW; Kim KS
    Biochem J; 2011 Jan; 433(1):225-33. PubMed ID: 20958264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
    McCarthy HO; Coulter JA; Worthington J; Robson T; Hirst DG
    J Gene Med; 2007 Jun; 9(6):511-20. PubMed ID: 17471586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
    Locke JA; Wasan KM; Nelson CC; Guns ES; Leon CG
    Prostate; 2008 Jan; 68(1):20-33. PubMed ID: 18000807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism.
    Sainz RM; Mayo JC; Tan DX; León J; Manchester L; Reiter RJ
    Prostate; 2005 Apr; 63(1):29-43. PubMed ID: 15378522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
    Inoue T; Maeno A; Talbot C; Zeng Y; Yeater DB; Leman ES; Kulkarni P; Ogawa O; Getzenberg RH
    Prostate; 2009 Jun; 69(8):861-73. PubMed ID: 19267365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
    Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
    Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.